Institutional Ownership
Wave Life Sciences Ltd
CUSIP Y95308105SHSWVEQ1 2026
13D / 13G Filings
53
Schedule 13D/13G on record
Beneficial Filers
26
Distinct reporting persons
Largest Stake
20.0%
Max % of class reported
Institutional Holders
223
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
53 filings · latest Feb 12, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 12, 2026 | Adage Capital Management, L.P. | 13G/A | 5.3% | 9.79M | SEC |
| 2 | Feb 5, 2026 | Fmr LLC | 13G | 8.5% | 15.02M | SEC |
| 3 | Dec 15, 2025 | Ra Capital Management, L.P. | 13D/A | 13.4% | — | SEC |
| 4 | Nov 13, 2025 | Ra Capital Management, L.P. | 13D/A | 14.6% | — | SEC |
| 5 | Aug 12, 2025 | Adage Capital Management, L.P. | 13G/A | 9.7% | 15.02M | SEC |
| 6 | May 12, 2025 | Adage Capital Management, L.P. | 13G/A | 8.2% | 12.52M | SEC |
| 7 | Feb 14, 2025 | Maverick Capital, Ltd. | 13G/A | 5.4% | 8.26M | SEC |
| 8 | Feb 5, 2025 | Blackrock, Inc. | 13G/A | 6.1% | 9.36M | SEC |
| 9 | Nov 12, 2024 | Gsk PLC | 13G/A | 11.2% | 16.78M | SEC |
| 10 | Nov 12, 2024 | M28 Capital Management LP | 13G/A | 4.2% | 6.16M | SEC |
43 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Wave Life Sciences Ltd.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 26.98M | $195.57M |
| 2 | Gsk PLC | 18.25M | $132.28M |
| 3 | Blackrock, Inc. | 14.12M | $102.35M |
| 4 | Maverick Capital Ltd | 10.16M | $73.67M |
| 5 | Driehaus Capital Management LLC | 5.43M | $39.37M |
| 6 | Federated Hermes, Inc. | 5.32M | $38.55M |
| 7 | Fmr LLC | 5.19M | $37.65M |
| 8 | 683 Capital Management, LLC | 4.90M | $35.52M |
| 9 | Primecap Management Co/Ca/ | 4.83M | $35.04M |
| 10 | M28 Capital Management LP | 4.59M | $33.27M |